De Paola V - Search Results

1

Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review.

Gennari L, Merlotti D, De Paola V, Calabrò A, Becherini L, Martini G, Nuti R. Gennari L, et al. Among authors: de paola v. Am J Epidemiol. 2005 Feb 15;161(4):307-20. doi: 10.1093/aje/kwi055. Am J Epidemiol. 2005. PMID: 15692074 Review.

2

Steroid hormone receptor gene polymorphisms and osteoporosis: a pharmacogenomic review.

Gennari L, De Paola V, Merlotti D, Martini G, Nuti R. Gennari L, et al. Among authors: de paola v. Expert Opin Pharmacother. 2007 Apr;8(5):537-53. doi: 10.1517/14656566.8.5.537. Expert Opin Pharmacother. 2007. PMID: 17376011 Review.

3

Update on the pharmacogenetics of the vitamin D receptor and osteoporosis.

Gennari L, Merlotti D, De Paola V, Martini G, Nuti R. Gennari L, et al. Among authors: de paola v. Pharmacogenomics. 2009 Mar;10(3):417-33. doi: 10.2217/14622416.10.3.417. Pharmacogenomics. 2009. PMID: 19290791 Review.

4

Characteristics and familial aggregation of Paget's disease of bone in Italy.

Merlotti D, Gennari L, Galli B, Martini G, Calabrò A, De Paola V, Ceccarelli E, Nardi P, Avanzati A, Nuti R. Merlotti D, et al. Among authors: de paola v. J Bone Miner Res. 2005 Aug;20(8):1356-64. doi: 10.1359/JBMR.050322. Epub 2005 Mar 28. J Bone Miner Res. 2005. PMID: 16007333 Free article.

5

The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels.

Martini G, Gennari L, De Paola V, Pilli T, Salvadori S, Merlotti D, Valleggi F, Campagna S, Franci B, Avanzati A, Nuti R, Pacini F. Martini G, et al. Among authors: de paola v. Thyroid. 2008 Apr;18(4):455-60. doi: 10.1089/thy.2007.0166. Thyroid. 2008. PMID: 18399769

6

Bazedoxifene for the prevention of postmenopausal osteoporosis.

Gennari L, Merlotti D, De Paola V, Martini G, Nuti R. Gennari L, et al. Among authors: de paola v. Ther Clin Risk Manag. 2008 Dec;4(6):1229-42. doi: 10.2147/tcrm.s3476. Ther Clin Risk Manag. 2008. PMID: 19337430 Free PMC article.

7

The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone.

Gennari L, Merlotti D, Mossetti G, Rendina D, De Paola V, Martini G, Nuti R. Gennari L, et al. Among authors: de paola v. Mini Rev Med Chem. 2009 Aug;9(9):1052-63. doi: 10.2174/138955709788922683. Mini Rev Med Chem. 2009. PMID: 19689402 Review.

8

Lasofoxifene: Evidence of its therapeutic value in osteoporosis.

Gennari L, Merlotti D, De Paola V, Nuti R. Gennari L, et al. Among authors: de paola v. Core Evid. 2010 Jun 15;4:113-29. doi: 10.2147/ce.s6001. Core Evid. 2010. PMID: 20694069 Free PMC article.

9

Professional sport activity and micronutrients: effects on bone mass.

Nuti R, Martini G, Merlotti D, Valleggi F, De Paola V, Gennari L. Nuti R, et al. Among authors: de paola v. J Endocrinol Invest. 2005;28(10 Suppl):52-60. J Endocrinol Invest. 2005. PMID: 16550724 Review.

10

Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.

Martini G, Gennari L, Merlotti D, Salvadori S, Franci MB, Campagna S, Avanzati A, De Paola V, Valleggi F, Nuti R. Martini G, et al. Among authors: de paola v. Bone. 2007 Feb;40(2):457-63. doi: 10.1016/j.bone.2006.08.003. Epub 2006 Sep 18. Bone. 2007. PMID: 16979395

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page